France: tough new pricing guidance with HTA focus
This article was originally published in Clinica
Executive Summary
The French government has issued guidance to its healthcare products pricing committee (CEPS), requiring that its pricing negotiations take into account the results of medico-economic evaluations – ie health technology assessments (HTAs).